共 50 条
- [2] VP-16-213 CHEMOTHERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF LUNG CANCER TREATMENT REPORTS, 1978, 62 (05): : 843 - 844
- [3] PHASE-II TRIAL OF VP-16 IN TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 365 - 365
- [4] ETOPOSIDE (VP-16) IN THE TREATMENT OF ADVANCED ADENOCARCINOMA OF THE PANCREAS AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (02): : 172 - 173
- [5] TREATMENT OF ADVANCED ADENOCARCINOMA OF THE BREAST WITH THE COMBINATION OF VP-16 AND ADRIAMYCIN PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 440 - 440
- [6] INCREASED CYTOTOXICITY OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK BY COMBINING CISPLATIN WITH VP-16 AND CIPROFLOXACIN LARYNGOSCOPE, 1993, 103 (10): : 1081 - 1083
- [7] PLATINUM (CDDP) + VINDESINE (VDS) (RXI), OR VP-16 (RXII), OR BOTH (RXIII) FOR ADENO - SQUAMOUS-CELL LUNG-CANCER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 152 - 152
- [8] CHEMOTHERAPY FOR ADVANCED ADENOCARCINOMA AND SQUAMOUS-CELL CARCINOMA OF THE LUNG WITH ETOPOSIDE AND CISPLATIN CANCER TREATMENT REPORTS, 1984, 68 (04): : 671 - 673
- [10] PHASE-II TRIAL OF VP-16 IN TREATMENT OF ADVANCED OVARIAN ADENOCARCINOMA PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 190 - 190